Evidence map›Paper›PMID 41395110›Full record

ArticleComputational and structural biotechnology journal2025

PanARGMiner (Pan-Genomic Antimicrobial Resistance Gene Miner): An advanced feature selection framework for extracting key resistance genes from pan-genomic datasets.

Yu-Cheng Chen, Ming-Ren Yang, Yu-Wei Wu

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Frontiers in bioinformatics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yu-Cheng ChenGraduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Ming-Ren YangGraduate Institute of Artificial Intelligence and Big Data in Healthcare, Smart Healthcare Interdisciplinary College, National Taipei University of Nursing and Health Sciences, Taipei 112, Taiwan.
Yu-Wei WuGraduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying antimicrobial resistance (AMR)-related biomarkers from large-scale genomic datasets is often akin to finding a needle in a haystack. With pan-genomic data containing more than 100,000 gene sequences, isolating features that truly drive resistance remains a major challenge in computational biology. Here we present PanARGMiner, a machine learning-based feature selection framework designed to robustly extract highly relevant and informative biomarkers from high-dimensional biological data. PanARGMiner uses an ensemble-based feature selection strategy to select highly informative and compact feature subsets. It then utilizes repeated iterations to ensure the stability and reliability of the proposed framework, enabling PanARGMiner to generate significantly reduced features with comparable prediction performance compared to those obtained with other feature selection algorithms. Applying PanARGMiner to bacterial pan-genomic antimicrobial resistance datasets successfully extracted as few as one to ten candidate AMR biomarkers from datasets with more than 100,000 genes for five common pathogens. Although many of the extracted candidate AMR biomarkers are well-known resistance genes, proteins not known to be associated with AMR mechanisms, including functionally uncharacterized hypothetical proteins, were also extracted. This indicates the potential of PanARGMiner in revealing both established and novel mechanisms of antibiotic resistance, thus providing actionable insights for biomarker discovery, functional genomics, and precision medicine based on complex data. Its ability to uncover both known and uncharacterized resistance-related features offers new opportunities for research and clinical applications in combating AMR.

Indexed as

Antimicrobial resistanceBiomarkerFeature selectionPanARGMinerPan-genome

Identifiers

PMID41395110
PMCPMC12699266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.